Improved results of atherosclerotic arch aneurysm operations with a refined technique  by Kazui, Teruhisa et al.
logic dysfunction, in patients who undergo aortic arch
repair for atherosclerotic aneurysms remain high
because of advanced age and comorbidities.1-4 In our
previous experience with 220 patients who underwent
aortic arch operations for various indications, including
atherosclerotic arch aneurysm (100 patients), the in-
hospital mortality was 12.7%, and the postoperative
permanent and temporary neurologic dysfunctions were
3.3% and 6%, respectively.5
The purpose of the present study was to evaluate
whether our recent refined technique was able to
reduce the in-hospital mortality and postoperative
With recent improvement in surgical technique ofaortic arch reconstruction and cerebral protection
methods during aortic arch repair, outcomes of aortic
arch aneurysm operations have remarkably improved.
However, mortality and morbidities, including neuro-
Objective: We sought to analyze the postoperative hospital mortality and
postoperative neurologic dysfunction in patients who had total arch replace-
ment for atherosclerotic arch aneurysms using our recent refined technique.
Methods: Between June 1997 and April 2000, 50 consecutive patients under-
went total arch replacement with an aortic arch branched graft for athero-
sclerotic arch aneurysms. Their mean age was 71 ± 7 years (range, 57-87
years). Forty-eight (96%) patients were operated on electively, and the
remaining 2 (4%) were operated on an emergency basis because of rupture
of aneurysm. All operations were performed with hypothermic extracorpo-
real circulation, selective cerebral perfusion for cerebral protection during
aortic arch repair, and systemic circulatory arrest during distal graft anasto-
mosis. A total of 19 concomitant procedures were done in 17 patients. Mean
selective cerebral perfusion time was 78.1 ± 16.5 minutes.
Results: Overall in-hospital mortality was 2% (95% confidence intervals,
0%-5.9%). On univariable analysis, permanent neurologic dysfunction was
the only risk factor for in-hospital mortality. Postoperative temporary and
permanent neurologic dysfunctions were 4% (95% confidence intervals, 0%-
9.4%) and 4% (95% confidence intervals, 0%-9.4%), respectively. On uni-
variable analysis, cardiopulmonary bypass time was the only risk factor for
temporary neurologic dysfunction, and history of cerebrovascular disease
was the only risk factor for permanent neurologic dysfunction. There was no
significant correlation between selective cerebral perfusion time and tempo-
rary and permanent neurologic dysfunction.
Conclusion: Integrated cerebral protective effect of antegrade selective cere-
bral perfusion and total arch replacement with an aortic arch branched graft
could substantially reduce in-hospital mortality and postoperative neurolog-
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neurologic dysfunction in this particular group of
patients.
Material and methods
Patient profile. Fifty consecutive patients with atheroscle-
rotic arch aneurysms underwent total arch replacement with
the aid of hypothermic cardiopulmonary bypass (CPB) and
antegrade selective cerebral perfusion (SCP) between June
1997 and April 2000. The patients ranged in age from 57 to
86 years, with a mean of 71 ± 7 years. Thirty-three (66%)
were male patients, and 17 (34%) were female patients. Six
(12%) patients had an aneurysm that involved the ascending
aorta and the whole of the arch, 10 (20%) had an aneurysm
involving the entire aortic arch, and 34 (68%) had distal arch
aneurysm with or without extension to the descending aorta.
Forty-eight (96%) patients were operated on electively, and
the remaining 2 (4%) were operated on on an emergency
basis because of rupture of aneurysm.
Preoperative comorbidities included coronary artery dis-
ease in 11 (22%) patients; chronic obstructive pulmonary dis-
ease in 6 (12%) patients; aortic valvular disease in 3 (6%)
patients; history of cerebrovascular disease in 9 (18%)
patients, including old cerebral infarct in 6 (12%) patients;
chronic renal failure in 4 (8%) patients, with 2 requiring
hemodialysis; abdominal aortic aneurysm in 3 (6%) patients;
aortoiliac occlusive disease in 1 (2%) patient; hypertension in
26 (56%) patients; and diabetes mellitus in 2 (4%) patients.
Six (12%) patients had previous operations, including aor-
toiliac graft replacement for abdominal aortic aneurysm in 5
(10%) patients and descending aortic graft replacement for
descending aortic aneurysm in 1 (2%) patient. Another 3
(6%) patients had previous percutaneous transluminal coro-
nary angioplasty for coronary artery disease.
Preoperative aortography or digital subtraction angiogra-
phy, including cerebral 4-vessel angiography, and cerebral
computed tomography were performed in all patients under-
going elective procedures.
Operative technique. All operations were performed
through a median sternotomy, with an extension of the inci-
sion to the left supraclavicular region. Table I summarizes the
extent of the operative procedure done in this series. The
details of hypothermic CPB and antegrade SCP have been
described previously.6,7 During CPB, arterial blood pH was
managed according to the alpha-stat strategy. As for the site
of arterial cannulation for CPB, the ascending aorta was
selected in the recent 34 (68%) patients, whereas the femoral
artery was selected in the remaining 16 (32%) patients.
Before the ascending aorta was cannulated, epiaortic ultra-
sonography scanning and transesophageal echocardiography
were routinely performed to assess whether atherosclerotic
plaques are present in the ascending aorta and the aortic arch.
For SCP, a newly developed flexible perfusion cannula
(Fuji System Corporation, Tokyo, Japan) was used in the
most recent patients. This cannula has two lumina, one for
blood perfusion and the other for pressure monitoring. A bal-
loon at the tip prevents slippage of the cannula when inflated
after cannulation of the arch vessels. The cannula, because of
its flexible metallic support, can be bent manually at the
desired angle without causing any luminal compromise. This
property allows the surgeon to place the cannula toward the
patient’s head side so that it does not obscure the operative
field. The temperature of the antegrade cerebral perfusate was
22°C during SCP.
Real-time intraoperative monitoring of SCP is important to
assess whether cerebral perfusion is adequate. First, we mon-
itor the perfusion pressure and flow rate of SCP. For the per-
fusion pressure of SCP, the right radial artery pressure and the
bilateral catheter tip pressure are routinely monitored. Two-
channel serial electroencephalography to monitor the cere-
bral electrical activity and 2-channel near infrared spec-
troscopy (Hamamatsu Photonix, Hamamatsu, Japan) to
estimate regional cerebral oxygenation are used. These tech-
niques also assess discrepancies of cerebral circulation
between the 2 cerebral hemispheres. In addition to these,
internal jugular venous oxygen saturation is used to monitor
cerebral oxygen consumption.
Vascular prostheses used in all patients were commercially
available collagen-pretreated aortic arch grafts with 4 limbs
(Hemashield Branched Graft; Meadox Medical, Oakland,
NJ). The details of our recent technique of total arch replace-
ment with an aortic arch branched graft for atherosclerotic
aneurysm of the aortic arch are depicted in Fig 1. Under SCP
with systemic circulatory arrest at a rectal temperature of
22°C, the descending aorta just below the aneurysm is com-
pletely transected (Fig 1, B). The distal side of the arch graft
with 4 limbs is anastomosed to the stump of the descending
aorta by a 4-0 monofilament running suture with Teflon felt
reinforcement (Fig 1, C). The arch graft proximal to the
fourth limb is crossclamped, and systemic perfusion to the
lower half of the body is started from the fourth limb of the
arch graft (Fig 1, D). The third limb is then anastomosed to
the left subclavian artery by a 5-0 monofilament running
suture. Then the arch graft proximal to the third limb is cross-
clamped, and rewarming by means of CPB is started (Fig 1,
E). The proximal side of the arch graft is sutured to the stump
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Table I. Extent of the operative procedure
Extent No. of patients
Asc Ao + TAR 6
Asc Ao + TAR + composite graft 1
Asc Ao + TAR + LVA reconstruction 1
Asc Ao + TAR + AAA repair 1
Asc Ao + TAR + Des Ao 27
Asc Ao + TAR + Des Ao + LVA reconstruction 2
Asc Ao + TAR + Des Ao + CABG 7
Asc Ao + TAR + Des Ao + AVR + CABG 2
Asc Ao + TAR + Des Ao + AVR + A-F bypass 1
Asc Ao + TAR + Des Ao + AAA repair 2
Total 50
Asc Ao, Ascending aortic replacement; TAR, total arch replacement; LVA, left
vertebral artery; AAA, abdominal aortic aneurysm; Des Ao, descending aortic
replacement; AVR, aortic valve replacement; A-F, aorto-bifemoral.
of the ascending aorta by a 4-0 monofilament running suture
with Teflon felt reinforcement, the aortic arch graft is
declamped, and coronary circulation is started. The first limb
of the arch graft is anastomosed to the innominate artery with
a 5-0 monofilament running suture (Fig 1, F), and the second
limb is anastomosed to the left common carotid artery in the
same fashion (Fig 1, G). After the extracorporeal circulation
is terminated, the fourth limb of the arch graft, which is used
for antegrade systemic perfusion, is resected (Fig 1, H). 
The extent of aortic replacement was as follows: replacement
of the ascending aorta and total arch was performed in 9 (18%)
patients, and replacement of the ascending aorta, total arch, and
proximal descending aorta (defined as descending aortic
replacement with the distal anastomosis located from 5 to 10
cm distal to the origin of the left subclavian artery) was per-
formed in 41 (82%) patients. Concomitant procedures included
composite graft replacement with coronary reimplantation in 1
(2%) patient, coronary artery bypass grafting (CABG) in 9
(18%) patients, aortic valve replacement in 3 (6%) patients, left
vertebral artery reconstruction in 3 (6%) patients where the left
vertebral artery directly originated from the aortic arch, aorto-
iliac graft replacement for abdominal aortic aneurysm in 3 (6%)
patients, and aortobifemoral bypass grafting for aortoiliac
occlusive disease in 1 (2%) patient. Aortoiliac graft replacement
and aortobifemoral bypass grafting were performed through the
transperitoneal approach after termination of CPB and neutral-
ization of heparin.
Statistical method. The continuous data in this study are
expressed as the mean ± SD, and categoric variables are
expressed as percentages.
We analyzed 33 preoperative, perioperative, and postop-
erative risk factors for their possible effect on in-hospital
mortality and 31 risk factors for their possible effect on
postoperative neurologic outcome (Table II). First, all the
independent variables were analyzed by a univariable
analysis (Fisher exact test or Mann-Whitney analysis) to
determine whether any single variable influenced in-hospi-
tal mortality and postoperative neurologic outcome.
Variables that achieved P values of less than .2 in the uni-
variable analysis were examined with multivariable analy-
sis by using forward stepwise logistic regression to study
their independent predictability in influencing in-hospital
mortality and postoperative neurologic outcome. Survival
was estimated by the Kaplan-Meier method, with variabil-
ity expressed as ±95% confidence intervals (CI). All com-
putations were performed with the SPSS 6.1 for UNIX
(SPSS, Inc, Chicago, Ill) and Statview 5.0 (SAS Institute,
Cary, NC) statistical software packages.
Results
In-hospital mortality. There were no operative
deaths or 30-day mortality. One of the 50 patients died
during hospitalization, for an in-hospital mortality of
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Fig 1. Schema of our recent surgical technique of total arch replacement with aortic arch branched graft for athero-
sclerotic aneurysm.
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Table II. Univariable analysis of in-hospital mortality and neurologic outcome
In-hospital 
Patients mortality Temporary ND Permanent ND
Variables No. % No. % P value No. % P value No % P value
Sex
Male 33 66 0 0 NS 2 6 NS 1 3 NS
Female 17 34 1 6 0 0 1 6
Age (y)
50-59 4 8 0 0 NS* 0 0 NS* 0 0 NS*
60-69 13 26 0 0 0 0 0 0
70-79 29 58 1 3 1 3 2 7
≥80 4 8 0 0 1 25 0 0
Hypertension
Yes 26 52 1 4 NS 1 4 NS 2 8 NS
No 24 48 0 0 1 4 0 0
Diabetes
Yes 2 4 0 0 NS 0 0 NS 1 50 .08
No 48 96 1 2 2 4 1 2
CAD
Yes 11 22 1 9 NS 1 9 NS 1 9 NS
No 39 78 0 0 1 3 1 3
COPD
Yes 6 12 0 0 NS 0 0 NS 0 0 NS
No 44 88 1 2 2 5 2 5
AR
Yes 3 6 0 0 NS 0 0 NS 0 0 NS
No 47 94 1 2 2 4 2 4
Old cerebral infarct
Yes 6 12 0 0 NS 1 17 NS 1 17 NS
No 44 88 1 2 1 2 1 2
CVD
Yes 9 18 1 11 NS 1 11 NS 2 22 .03
No 41 82 0 0 1 2 0 0
Chronic renal failure
Yes 4 8 0 0 NS 0 0 NS 0 0 NS
No 46 92 1 2 2 4 2 4
AAA
Yes 3 6 0 0 NS 0 0 NS 0 0 NS
No 47 94 1 2 2 4 2 4
Aortoiliac occlusion
Yes 1 2 0 0 NS 0 0 NS 0 0 NS
No 49 98 1 2 2 4 2 4
Previous aortic operation
Yes 6 12 0 0 NS 0 0 NS 0 0 NS
No 44 88 1 2 2 5 2 5
Emergency
Yes 2 4 0 0 NS 0 0 NS 0 0 NS
No 48 96 1 2 2 4 2 4
Extent of replacement
Asc Ao + TAR 9 18 0 0 NS 0 0 NS 0 0 NS
Asc Ao + TAR 41 82 1 2 2 5 2 5
+ Des Ao
CABG
Yes 9 18 1 11 NS 1 11 NS 1 11 NS
No 41 82 0 0 1 2 1 2
Composite G
Yes 1 2 0 0 NS 0 0 NS 0 0 NS
No 49 98 1 2 2 4 2 4
AVR
Yes 3 6 0 0 NS 1 33 NS 0 0 NS
No 47 94 1 2 1 2 2 4
Continued.
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Table II. Cont’d
In-hospital 
Patients mortality Temporary ND Permanent ND
Variables No. % No. % P value No. % P value No % P value
AAA repair
Yes 3 6 0 0 NS 0 0 NS 0 0 NS
No 47 94 1 2 2 4 2 4
A-F bypass
Yes 1 2 0 0 NS 0 0 NS 0 0 NS
No 49 98 1 2 2 4 2 4
Arterial cannulation site
Femoral 16 32 0 0 NS 1 6 NS 1 6 NS
Asc Ao 34 68 1 3 1 3 1 3
CPB time (min)
100-149 16 32 0 0 NS* 0 0 .03 0 0 NS*
150-199 33 66 0 0 0 0 1 3
≥200 11 22 1 9 2 18 1 9
Ao CC time (min)
60-89 24 48 0 0 NS* 0 0 NS* 0 0 NS*
90-119 13 26 0 0 0 0 1 8
120-149 7 14 1 14 1 14 1 14
≥150 6 12 0 0 1 17 0 0
SCP time (min)
40-59 7 14 0 0 NS* 0 0 NS* 0 0 NS*
60-79 19 38 0 0 0 0 1 5
80-99 19 38 1 5 1 5 1 5
≥100 5 10 0 0 1 20 0 0
SCA time (min)
0-29 15 30 0 0 NS* 0 0 NS* 0 0 NS*
30-59 30 60 1 3 1 3 2 7
≥60 5 10 0 0 1 20 0 0
Postoperative temporary ND
Yes 2 4 0 0 NS — — — — — —
No 48 96 1 2 NS — — — — — —
Postoperative permanent ND
Yes 2 4 1 50 .04 — — — — — —
No 48 96 0 0 — — — — — —
Rethoracotomy for hemorrhage
Yes 2 4 0 0 NS 0 0 NS 0 0 NS
No 48 96 1 2 2 4 2 4
Postoperative pulmonary failure
Yes 6 12 1 17 NS 0 0 NS 1 17 NS
No 44 88 0 0 2 5 1 2
Postoperative renal failure
Yes 3 6 1 33 NS 1 33 NS 1 33 NS
No 47 94 0 0 1 2 1 2
Postoperative liver dysfunction
Yes 1 2 0 0 NS 0 0 NS 0 0 NS
No 49 98 1 2 2 4 2 4
Postoperative LOS (IABP)
Yes 1 2 1 100 .08 0 0 NS 1 100 NS
No 49 98 0 0 2 4 1 2
Postoperative A-E fistula
Yes 1 2 0 0 NS 0 0 NS 0 0 NS
No 49 98 1 2 2 4 2 4
NS, Not significant; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; AR, aortic regurgitation; CVD, cerebrovascular disease; AAA,
abdominal aortic aneurysm; Asc Ao, Ascending aortic replacement; TAR, total arch replacement; Des Ao, descending aortic replacement; composite G, composite
graft replacement; AVR, aortic valve replacement; A-F, aortobilateral femoral bypass; Ao CC, aortic crossclamping; SCA, systemic circulatory arrest; ND, neurolog-
ic dysfunction; LOS, low cardiac output syndrome; IABP, intra-aortic balloon pump; A-E, aortoesophageal fistula.
*Kruskal-Wallis analysis was not possible because of the small patient number in each group. Therefore, the variables in patients with or without postoperative neu-
rologic dysfunction were compared by the Mann-Whitney analysis.
2% (95% CI, 0%-5.9%). One patient who had an
ischemic stroke after a prolonged period of hypoxia
and shock caused by endotracheal intubation trouble
after the termination of extracorporeal circulation died
of aspiration pneumonia 6.4 months after the operation.
In-hospital mortality for patients who had permanent
neurologic dysfunction was 50%, whereas the inci-
dence was 0% for those without permanent neurologic
dysfunction. Table II shows univariable analysis of in-
hospital mortality and neurologic outcome. It revealed
that permanent neurologic dysfunction was the only
significant risk factor of in-hospital mortality. On mul-
tivariable analysis, however, no significant independent
predictor of in-hospital mortality was found.
In-hospital morbidity. Transient neurologic dysfunc-
tion, defined as postoperative confusion, agitation, and
delirium with negative computed tomography results and
complete resolution symptoms before discharge, was
observed in 2 (4.0%) of the 50 patients (95% CI, 0%-
9.4%). Univariable analysis revealed that CPB time was
the only variable to significantly influence temporary
neurologic dysfunction (Table II). On multivariable
analysis, however, no significant independent predictor of
temporary neurologic dysfunction was found.
Permanent neurologic dysfunction, defined as perma-
nent neurologic deficits with localizing neurologic
signs and a corresponding new defect observed on
computed tomographic scanning, was noted in only 2
(4.0%) of the 50 patients (95% CI, 0%-9.4%). One
patient sustained ischemic stroke because of endotra-
cheal intubation trouble after the termination of extra-
corporeal circulation, and the other underwent embolic
stroke. The patient with an embolic stroke recovered
well and was discharged with mild hemiplegia. Cause
of the stroke in this case might have been distal emboli
from the femoral artery perfusion. Univariable analysis
indicated that history of cerebrovascular disease was
the only variable to significantly influence permanent
neurologic dysfunction (Table II). Multivariable analy-
sis, however, did not show any independent predictor of
permanent neurologic dysfunction. The incidence of
postoperative temporary and permanent recurrent
laryngeal nerve injury was 10% (5 cases) and 6% (3
cases), respectively. There was, however, no incidence
of phrenic nerve injury. Other in-hospital morbidities
included hemorrhage requiring a repeat thoracotomy in
2 (4%) patients, pulmonary failure requiring support
with a respirator for more than 5 days after the opera-
tion in 6 (12%) patients, renal failure (defined as a
blood urea nitrogen level > 70 mg/dL or a serum crea-
tinine level of > 3.0 mg/dL) in 3 (6%) patients, liver
dysfunction (defined as a total bilirubin level >3.0
mg/dL or glutamic pyruvic transaminase level > 100 U)
in 1 (2%) patient, and low cardiac output necessitating
an intra-aortic balloon pump in 1 (2%) patient. One
patient had a graft-esophageal fistula after the ascend-
ing aorta, total arch, and descending aortic replace-
ment, which was successfully treated with direct repair
of the esophageal perforation with wrapping by pedi-
cled intercostal muscle and debridement and antibiotic
irrigation, followed by omental wrapping of the graft.
This patient is now in good condition and is free from
infection 10 months after the operation.
Extracorporeal circulation data. Mean CPB time
was 173.5 ± 47.1 minutes, mean aortic crossclamp time
was 100.2 ± 33.9 minutes, mean systemic circulatory
arrest time was 39.2 ± 14.6 minutes, and mean SCP
time was 78.1 ± 16.5 minutes. Fig 2 shows patient dis-
tribution according to SCP time. Twenty-four (48%)
patients had an SCP time of longer than 80 minutes. No
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Fig 2. Patient distribution according to SCP time.
significant correlation was found between SCP time
and temporary and permanent neurologic dysfunction.
Medium-term survival. Fig 3 shows the actuarial
survival curves estimated by the Kaplan-Meier method.
The 24-month survival, including in-hospital death,
was 92% (95% CI, 84%-100%).
During a mean follow-up period of 15.3 months
(range, 1-36 months), there were 2 deaths. One patient
died of rupture of the descending aorta after an acute
type B dissection 3.6 months after the operation. The
other died of a cerebrovascular accident 4.7 months
after the operation.
Discussion
Reducing the incidence of postoperative stroke is a
formidable challenge in the field of cardiac surgery.
Despite recent improvements in operative techniques
and preoperative and intraoperative management, the
stroke rate after CABG has remained relatively unal-
tered. The reported incidence of stroke after CABG is
in the range of 1% to 6%.8-11 Atherosclerosis of the
ascending aorta, carotid arterial disease, and older
age have been identified as risk factors for postoper-
ative stroke. The 1997 Society of Thoracic Surgeons
National Cardiac Surgery Database reported a post-
operative permanent stroke rate of 1.65%, transient
stroke rate of 0.74%, delirium rate of 2.62%, and rate
of continuous coma for more than 24 hours of 0.43%
after CABG.12 Stroke after CABG obviously increas-
es the in-hospital mortality and adversely influences
the length of hospital stay. Therefore, a thorough
evaluation of the preoperative risk factors and appro-
priate intraoperative measures to reduce cerebral
embolic and ischemic events are mandated.
Postoperative stroke generally has a higher incidence
after aortic arch operations for atherosclerotic
aneurysm than after CABG. Because surgery for ath-
erosclerotic arch aneurysm poses some additional
risk of cerebral embolism and requires cerebral pro-
tection against ischemia during aortic arch exclusion,
the incidence of postoperative neurologic dysfunc-
tion after this type of operation is likely to be even
higher.
Some recent reports indicate that 30-day or in-hospi-
tal mortality rates after aortic arch operations for ath-
erosclerotic aneurysm range from 6.3% to 20%, and
the stroke rates for this type of operation vary from
4.0% to 11%.1-4,13,14 Compared with these results, the
2% in-hospital mortality, 4% temporary neurologic
dysfunction, and 4% permanent neurologic dysfunc-
tion that we had in our series are satisfactory outcomes.
Generally speaking, antegrade SCP as the brain
protection method has been instrumental for us in
improving the outcomes of aortic operations, and we
have already reported its unique advantages.5-7,15
Although postoperative stroke in aortic arch opera-
tions usually results from cerebral emboli and has
nothing to do with the cerebral protection method,1,2
our 4% temporary neurologic dysfunction is marked-
ly lower than the 20% to 25% in other series in which
profound hypothermia and circulatory arrest with or
without retrograde cerebral perfusion have been
used.2,16 In addition to that, although operating for
atherosclerotic arch aneurysms, we adopt the follow-
ing special measures to avoid cerebral embolic
events: if the aneurysm is located in the distal aorta
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Fig 3. Medium-term survival of patients undergoing total arch replacement for atherosclerotic aneurysm.
or if there are severe atheroscletic lesions, we prefer
to cannulate the ascending aorta for instituting CPB.
Before cannulating the ascending aorta for CPB,
epiaortic 2-dimensional ultrasonography is per-
formed to determine an atherosclerotic plaque-free
site for the cannulation. This contributes to reduced
cerebral embolism from the ascending aorta.
Furthermore, to reduce embolic phenomena from the
distal aorta, antegrade perfusion through the fourth
limb of the arch graft is initiated after the distal anas-
tomosis is completed. The fact that we changed the
arterial cannulation site during the course of this
study is significant. Of the earlier 16 patients of this
series who had femoral artery cannulation, 1 patient
had embolic cerebral stroke. Then we switched to
ascending aortic cannulation. However, the issue of
the most suitable cannulation site for patients with
atherosclerotic arch aneurysm continues to be inves-
tigated. The right subclavian artery or axillary artery
have come up as possible options.17 Fortunately, in
the 34 patients of this series in whom we performed
ascending aortic cannulation, the ascending aorta was
found to be a good cannulation site by means of
epiaortic ultrasonographic scanning. However, if the
ascending aorta would be unsuitable, our next choice
would be the right axillary artery. In fact, we have
already used axillary artery cannulation at our insti-
tution and have obtained good results.
One of the key points about SCP is the arch vessel
cannulation. We believe that our newly developed per-
fusion cannula and our recently refined cannulation
technique made it easier for us to avoid the cannula-
tion-related complications, such as cerebral emboliza-
tion of dislodged atherosclerotic debris or air. Because
atherosclerotic lesions are commonly located at the ori-
gins of the arch vessels, it is very important to transect
them at places where they are free from such lesions to
avoid dislodgment of atherosclerotic debris. Again,
while cannulating, we meticulously evacuate air from
the cannulas to reduce the incidence of air embolism.
Our newly developed perfusion cannula is very con-
venient in use because it can be bent at right angles
with the help of its flexible metallic support and also
allows pressure monitoring.
It has been recognized that atherosclerosis of the
ascending aorta is a major cause of stroke after 
CABG18-20 and also after aortic arch operations.2
Therefore, our philosophy about the extent of aortic
replacement in this type of operation is that all the poten-
tial sources of cerebral embolism must be radically
removed, and that is why we also replace the ascending
and the descending aorta in addition to performing the
arch replacement. In these operations the site of aortic
cannulation and that for infusion of cardioplegic solution
are also resected because they are potential sources of
cerebral emboli.20 We have extensively used the separat-
ed graft technique by using the aortic arch branched graft
for atherosclerotic arch aneurysm. This technique has
several advantages when compared with en bloc repair, in
which the arch vessels are anastomosed to the side hole
of the arch graft in an island fashion. The use of a sepa-
rated graft technique automatically excludes the athero-
sclerotic lesions at the origins of the arch vessels and also
allows us to easily control bleeding from the arch vessel
anastomosis. These can reduce the incidence of postop-
erative neurologic dysfunction.
The presence of carotid arterial disease is another
risk factor of stroke after cardiac surgery. We routinely
perform preoperative cerebral 4-vessel angiography
and cerebral computed tomographic scanning to rule
out carotid arterial disease, and we have not encoun-
tered this important lesion in our series.
A history of cerebrovascular disease was also a sig-
nificant risk factor of stroke in our series, which is con-
sistent with other studies on CABG9,11 and aortic arch
operations with profound hypothermia and circulatory
arrest with or without retrograde cerebral perfusion.1,2
A history of cerebrovascular disease suggests existing
pathologic cerebrovascular conditions, such as im-
paired cerebral blood flow and autoregulation or inad-
equate collateral vessels, which may predispose
patients to having a stroke after cardiovascular opera-
tions. Therefore, for patients with old cerebrovascular
disease, further improvement in brain protection meth-
ods will be necessary.
In summary, surgery for atherosclerotic arch
aneurysm carries a high risk of perioperative cerebral
embolism and therefore generally has a higher postop-
erative stroke rate. However, our refined surgical tech-
nique for this kind of operation allowed us to signifi-
cantly reduce mortality and postoperative neurologic
dysfunction.
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